QQ客服 官方微博 反馈留言

	Research progress on the anti-rheumatoid arthritis drugs
	Wang, Peng ; Luo, Xuegang ; Wang, Chongxi ; Wang, Xinjia ; Hu, Guang ; Zhang, Tong-Cun
	2014
DOI	10.1007/978-3-642-37922-2-94
英文摘要	Rheumatoid arthritis (RA) is a chronic systemic autoimmune disease leading to synovial hyperplasia and a series of multisystem comorbidities. Permanent disability usually occurs in 20-30 % of untreated patients within 2-3 years of the disease. Therefore, it is important to diagnose the disease and initiate treatment as early as possible. The drug therapy plays an important role in maintaining a state of very low disease activity and slowing the progression of joint damage. Traditional drug therapy in RA is a pyramid approach, in which nonsteroidal anti-inflammatory drugs (NSAIDs) serve as the base of pyramid and disease-modifying antirheumatic drugs (DMARDs) are employed relatively late. But since this approach is no longer valid, many new drugs used to manage RA have been developed. In this review, we specifically summarize the current drug therapies for the treatment of RA and briefly describe the etiology, pathology and pathogenesis of RA. ? Springer-Verlag Berlin Heidelberg 2014.; EI; 0
语种	英语
内容类型	会议论文
源URL	[http://ir.pku.edu.cn/handle/20.500.11897/412496]
专题	工学院
推荐引用方式 GB/T 7714	Wang, Peng,Luo, Xuegang,Wang, Chongxi,et al. Research progress on the anti-rheumatoid arthritis drugs[C]. 见:.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。